Shawn,
Ofcourse the approval of fluticare is not a 100% guarantee. If it was then it would already be reflected in the current share price (baked in). However because it's not baked into the share price, this is why we have tremendous upside, with of course a degree of risk (rejection of fluticare).
Although I would concede that the FDA is not beyond reproach. I would not count on a FDA conspiracy to reject fluticare.
Folks throwing around random arbitrary percentages of approval and rejection are simply that...Random & arbitrary.
Locked in since .09 for a good sum of shares. You can't argue management is hell-bent on the success of the company. Including fluticare approval, up listing to a major exchange, Beyond Human products, and potentially a buy-out.
